IXICO plc (FRA:PYPB)

Market Cap	26.16M +104.3%
Revenue (ttm)	8.33M +13.0%
Net Income	-2.08M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	376
Open	0.1060
Previous Close	0.0905
Day's Range	0.1060 - 0.1060
52-Week Range	0.0655 - 0.1530
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 4, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Bram Goorden
• Employees: 79
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PYPB

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error